Agile Therapeutics to Participate in Upcoming Investor Conferences

Rhea-AI Summary

Agile Therapeutics (Nasdaq: AGRX) announced participation in several virtual investor conferences in September 2021. Key events include the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 20, and the Cantor Fitzgerald Virtual Global Healthcare Conference from September 27-30. Presentations will feature live webcasts available on their Investor Relations website. Agile is focused on women's healthcare with products like the transdermal contraceptive, Twirla.

PRINCETON, N.J., Sept. 07, 2021 (GLOBE NEWSWIRE) -- Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following virtual investor conferences during the month of September 2021.

H.C. Wainwright 23rd Annual Global Investment Conference (September 13-15, 2021)

• Date: On-Demand Beginning Monday, September 13, 2021 at 7 a.m. ET
  
  
• Webcast: https://journey.ct.events/view/f135776a-907f-4644-bb11-7c4619d6cabf

Oppenheimer Fall Healthcare Life Sciences & MedTech Summit (September 20-23, 2021)

• Date: Monday, September 20, 2021
  
  
• Presentation Time: 3:45p.m. ET
  
  
• Webcast: https://wsw.com/webcast/oppenheimer16/agrx/2786806
  

Cantor Fitzgerald Virtual Global Healthcare Conference 2021 (September 27-30, 2021)

• Date: Wednesday, September 29, 2021
  
  
• Presentation Time: 3:20 p.m. ET
  
  
• Webcast: https://wsw.com/webcast/cantor12/agrx/2089780
  

Live webcasts of all presentations and any accompanying presentation materials, as well as the archived recordings, will be available on the Company's Investor Relations website, https://ir.agiletherapeutics.com/. Following each conference, archived recordings will be available on the Company’s website for at least 30 days.

For more information or to schedule a meeting with Agile management, please contact your conference representative or Matt Riley via email at mriley@agiletherapeutics.com.

About Agile Therapeutics, Inc.

Agile Therapeutics is a women's healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website.

Contact: 
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

FAQ

When will Agile Therapeutics present at the H.C. Wainwright conference?

Agile Therapeutics will present at the H.C. Wainwright 23rd Annual Global Investment Conference from September 13-15, 2021.

What is the date and time of Agile Therapeutics' presentation at the Oppenheimer Summit?

Agile Therapeutics' presentation at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit is scheduled for September 20, 2021, at 3:45 p.m. ET.

When is the Cantor Fitzgerald Global Healthcare Conference taking place?

The Cantor Fitzgerald Virtual Global Healthcare Conference will occur from September 27-30, 2021, with Agile's presentation on September 29 at 3:20 p.m. ET.

Where can I find the webcasts for Agile Therapeutics' investor presentations?

Webcasts of Agile Therapeutics' presentations can be found on their Investor Relations website, with recordings available for at least 30 days after each event.

What does Agile Therapeutics focus on?

Agile Therapeutics is dedicated to women's healthcare, providing contraception options like Twirla, a non-daily transdermal contraceptive.